D,
CYT are going to pay you for it, not seal it.
Avx and the BOD are only offering you a share of the costly ph3 with big risk. Its the same situation as they had with ip-88. No partner, to validate the drug the only difference if the drug is spelt ACT not PI-88.
And don’t give me the spin, about “near term value inflection points” and “discussion with several parties” because we have heard it all before.
D,CYT are going to pay you for it, not seal it.Avx and the BOD...
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
